LGM-20545-22812
1 vaccination
2 coded responses
3 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 300 / GA
- Registered
- 2022-07-10
- Relationship
- Child or adolescent in my care
- Guardian
- 3QR-14185-22314
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-29
Dose 1 — Pfizer-BioNTech
-
2022-07-10
Registered in v-safe
-
2022-07-10
Survey response — day 7, dose 1, dependentMedDRA: Injection site bruising — Feeling: Good · Site: Pain, SwellingFree text: Bruise at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-07-13
-
2023-06-29
Survey response — 12 months, dose 1, dependentMedDRA: Ear infection, Nasopharyngitis, Pyrexia — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-29 | Pfizer-BioNTech | No |
Free text
Release 12 — day 7, dose 1, dependent
Systemic reaction (other): Bruise at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release